{"disease":{"id":"chemoradiation","name":"chemoradiation"},"drugs":{"marketed":[{"drug_id":"osimertinib","indication_name":"Treatment of adult patients with locally advanced, unresectable (stage III) NSCLC whose disease has not progressed during or following concurrent or sequential platinum-based chemoradiation therapy and whose tumors have EGFR exon 19 deletions or exon 21 L858R mutations","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tagrisso","generic_name":"osimertinib","company_name":"AstraZeneca","drug_phase":"marketed","molecular_target":"ALK tyrosine kinase receptor","drug_class":"Kinase Inhibitor [EPC]","quality_score":67,"revenue":"5800","mechanism":"Osimertinib is a kinase inhibitor of the epidermal growth factor receptor (EGFR) that binds irreversibly to mutant forms of EGFR."},{"drug_id":"hydroxyurea","indication_name":"Locally advanced squamous cell carcinomas of the head and neck (excluding lip) in combination with concurrent chemoradiation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"HYDROXYUREA","company_name":"","drug_phase":"marketed","molecular_target":"Ribonucleotide reductase","drug_class":"Antimetabolite [EPC]","quality_score":65,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":2,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03461341","title":"European iNvestigation of SUrveillance After Resection for Esophageal Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":3000,"lead_sponsor_name":"St. James's Hospital, Ireland","has_results":false},{"nct_id":"NCT03298204","title":"Definitive (Chemo)Radiotherapy for Patients With Esophageal Cancer - 3JECROG R-01","phase":"","overall_status":"COMPLETED","enrollment_count":2762,"lead_sponsor_name":"Chinese Academy of Medical Sciences","has_results":false},{"nct_id":"NCT04821843","title":"Neoadjuvant Treatment Modalities in Esophageal Cancer","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","has_results":false},{"nct_id":"NCT04821778","title":"Chemoradiotherapy in Esophageal or Esophagogastric Junction Cancer","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","has_results":false},{"nct_id":"NCT03623737","title":"Comparing Paclitaxel/Cisplatin and Cisplatin/5-fluorouracil in Neo-CRT for ESCC","phase":"PHASE2, PHASE3","overall_status":"UNKNOWN","enrollment_count":248,"lead_sponsor_name":"National Taiwan University Hospital","has_results":false},{"nct_id":"NCT05215379","title":"Neoadjuvant Chemoradiation Therapy Combined With Immunotherapy for MSS Ultra-low Rectal Cancer","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":201,"lead_sponsor_name":"Changhai Hospital","has_results":false},{"nct_id":"NCT03923309","title":"Oncologic Risk of Rectal Preservation Against Medical Advice After Chemoradiotherapy for Rectal Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":142,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT03225300","title":"Simultaneous Integrated Boost in Malignant Glioma Patients Treated With Chemoradiation","phase":"NA","overall_status":"UNKNOWN","enrollment_count":120,"lead_sponsor_name":"Taichung Veterans General Hospital","has_results":false},{"nct_id":"NCT03283527","title":"Organoid Based Response Prediction in Esophageal Cancer","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"University Medical Center Groningen","has_results":false},{"nct_id":"NCT03731130","title":"Prospective Observational Trial to Evaluate Quality of Life After Neoadjuvant Radiation or Chemoradiation Followed by Surgery in Patients With Rectal Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Ludwig-Maximilians - University of Munich","has_results":false},{"nct_id":"NCT03840239","title":"TNT to Increase the Clinical Complete Response Rate for Distal LARC","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":98,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT03577808","title":"Organoids in Predicting Chemoradiation Sensitivity on Rectal Cancer","phase":"","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"Zhen Zhang","has_results":false},{"nct_id":"NCT06181656","title":"Serologic Response to Pneumococcal Vaccination Among Esophageal Cancer Patients With High Grade Lymphopenia After Chemoradiation","phase":"","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT03475186","title":"Testing Ramipril to Prevent Memory Loss in People With Glioblastoma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":75,"lead_sponsor_name":"Wake Forest University Health Sciences","has_results":true},{"nct_id":"NCT03712774","title":"Prospective Observational Trial to Evaluate Quality of Life After Neoadjuvant or Definitive Chemoradiation in Patients With Esophageal Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Ludwig-Maximilians - University of Munich","has_results":false},{"nct_id":"NCT03066271","title":"Pre Radiotherapy Daily Exercise Training in Non-Small Cell Lung Cancer","phase":"NA","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"Rigshospitalet, Denmark","has_results":false},{"nct_id":"NCT05394415","title":"Chemoradiation Plus Tislelizumab for Conversion Therapy of Locally Nonresectable ESCC","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Jiangsu Cancer Institute & Hospital","has_results":false},{"nct_id":"NCT03170115","title":"Induction Chemotherapy Plus Chemoradiotherapy With or Without Aspirin in High Risk Rectal Cancer","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":25,"lead_sponsor_name":"Instituto Nacional de Cancer, Brazil","has_results":false},{"nct_id":"NCT05758116","title":"Tislelizumab Consolidation Therapy After Radiotherapy or Sequential Chemoradiation in Locally Advanced NSCLC Patients","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Peking University Cancer Hospital & Institute","has_results":false},{"nct_id":"NCT03427684","title":"Study of Hypo-fractionated Neoadjuvant Radiotherapy for Locally Advanced Gastric Cancer","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":18,"lead_sponsor_name":"Chinese Academy of Medical Sciences","has_results":false}],"total":20},"guidelines":[],"source":"Drug Landscape verified database"}